Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

¥53.24As of Sun 8 Nov 2026, 12:00 UTC
SSE:688621Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (2.84%)
Div yield 0.35%
ROE 0.54%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.18
PE TTM 978.4
TSR TTM (9.04%)
Mkt cap ¥5.818B
ROIC 2.65%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥65
22.18%
(54.25%)
Hold 11|0|11|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.94
0.93
0.97
1.03
7.92%
3.24%
5.98%
17.45%
Revenue¥M
329.4
337.6
340.5
347.4
16.38%
18.37%
14.17%
11.73%
Peers (US$872.1M)
Cap (US$)
PE
867.0M
41.80x
866.6M
46.93x
864.4M
29.67x
Capital
TTM
5Y
10Y
Leveragex
8.421
0.354
0.237
EBIT/Intx
0.708
0.628
0.608
Own earn%
(77.38)
(113.90)
(97.25)
Sh yield%
13.62
35.79
34.86
Owners
Insiders/Inst%
13.33
89.83
Short interest%
3.51
SBC / revenue%
3.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
18–26
$1 testx
0.0
Incr. ROIC%
51